Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

This proof-of-concept randomized controlled clinical trial explores the safety, feasibility, and preliminary efficacy of psilocybin-enhanced psychotherapy versus treatment-as-usual among military Veterans being treated for methamphetamine use disorder within a residential treatment facility.

Sponsor: Steven & Alexandra Cohen Foundation; SN Charitable Foundation; OHSU Foundation; study drug provided by Usona Institute

MDMA-Assisted Group Therapy for Veterans with PTSD

This proof-of-concept clinical trial is the first to explore the safety and feasibility of MDMA-assisted psychotherapy conducted in a group therapy format. Participants will be military Veterans with PTSD.

Sponsor: Multidisciplinary Association for Psychedelic Studies (MAPS); Steven & Alexandra Cohen Foundation

MDMA-Assisted Group Therapy for PTSD and Minority Stress Among Transgender & Gender Diverse People

We conducted a focus group regarding trauma-related mental health experiences among gender diverse individuals in order to inform a more inclusive approach to the development of MDMA-assisted therapy for this marginalized group. Stay tuned for the development of a multisite clinical trial...

Collaborators: OHSU Dept of Psychiatry; OHSU Transgender Health Program; Encircle; study drug provided by MAPS PBC

MDMA-Assisted Therapy for Social Anxiety Disorder

This proof-of-concept randomized controlled clinical trial evaluates the safety and effectiveness of MDMA-assisted therapy for adults with social anxiety disorder.

Principal Investigator: Jason Luoma, PhD - Portland Psychotherapy Clinic